ID   DHCR7_HUMAN             Reviewed;         475 AA.
AC   Q9UBM7; B2R6Z2; O60492; O60717;
DT   31-JAN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   15-MAR-2017, entry version 165.
DE   RecName: Full=7-dehydrocholesterol reductase;
DE            Short=7-DHC reductase;
DE            EC=1.3.1.21;
DE   AltName: Full=Putative sterol reductase SR-2;
DE   AltName: Full=Sterol Delta(7)-reductase;
GN   Name=DHCR7; Synonyms=D7SR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS SLOS LEU-119; ARG-244 AND
RP   CYS-248.
RX   PubMed=9683613; DOI=10.1086/301982;
RA   Waterham H.R., Wijburg F.A., Hennekam R.C.M., Vreken P.,
RA   Poll-The B.T., Dorland L., Duran M., Jira P.E., Smeitink J.A.M.,
RA   Wevers R.A., Wanders R.J.A.;
RT   "Smith-Lemli-Opitz syndrome is caused by mutations in the 7-
RT   dehydrocholesterol reductase gene.";
RL   Am. J. Hum. Genet. 63:329-338(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND VARIANT LEU-5.
RC   TISSUE=Liver;
RX   PubMed=9465114; DOI=10.1073/pnas.95.4.1899;
RA   Moebius F.F., Fitzky B.U., Lee J.N., Paik Y.K., Glossmann H.;
RT   "Molecular cloning and expression of the human delta7-sterol
RT   reductase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:1899-1902(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9878250; DOI=10.1006/geno.1998.5615;
RA   Holmer L., Pezhman A., Worman H.J.;
RT   "The human lamin B receptor/sterol reductase multigene family.";
RL   Genomics 54:469-476(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT LEU-5.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-475.
RC   TISSUE=Liver;
RX   PubMed=9634533; DOI=10.1086/301936;
RA   Wassif C.A., Maslen C., Kachilele-Linjewile S., Lin D., Linck L.M.,
RA   Conner W.E., Steiner R.D., Porter F.D.;
RT   "Mutations in the human sterol delta 7-reductase gene at 11q12-13
RT   cause Smith-Lemli-Opitz syndrome.";
RL   Am. J. Hum. Genet. 63:55-62(1998).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   VARIANTS SLOS SER-51; MET-93; PRO-99; PRO-157; VAL-247; LEU-326;
RP   TRP-352; SER-380; CYS-404 AND SER-410.
RX   PubMed=9653161; DOI=10.1073/pnas.95.14.8181;
RA   Fitzky B.U., Witsch-Baumgartner M., Erdel M., Lee J.N., Paik Y.-K.,
RA   Glossmann H., Utermann G., Moebius F.F.;
RT   "Mutations in the delta7-sterol reductase gene in patients with the
RT   Smith-Lemli-Opitz syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8181-8186(1998).
RN   [18]
RP   VARIANTS SLOS SER-51; MET-93; PRO-99; HIS-107; PRO-109; ASP-147;
RP   MET-154; PRO-157; LEU-169; CYS-182; CYS-242; VAL-247; MET-281;
RP   ILE-289; GLY-311; TYR-311; HIS-324; LEU-326; GLN-352; TRP-352;
RP   ALA-353; CYS-362; TYR-380; ARG-380; SER-380; LEU-397; CYS-404;
RP   SER-404; HIS-408; SER-410; ARG-410; CYS-443; GLN-446; GLN-448; LYS-448
RP   AND LEU-450.
RX   PubMed=10677299; DOI=10.1086/302760;
RA   Witsch-Baumgartner M., Fitzky B.U., Ogorelkova M., Kraft H.G.,
RA   Moebius F.F., Glossmann H., Seedorf U., Gillessen-Kaesbach G.,
RA   Hoffmann G.F., Clayton P., Kelley R.I., Utermann G.;
RT   "Mutational spectrum in the Delta7-sterol reductase gene and genotype-
RT   phenotype correlation in 84 patients with Smith-Lemli-Opitz
RT   syndrome.";
RL   Am. J. Hum. Genet. 66:402-412(2000).
RN   [19]
RP   VARIANT SLOS ILE-289.
RX   PubMed=10995508;
RX   DOI=10.1002/1096-8628(20000918)94:3<214::AID-AJMG7>3.3.CO;2-I;
RA   Krakowiak P.A., Nwokoro N.A., Wassif C.A., Battaile K.P.,
RA   Nowaczyk M.J.M., Connor W.E., Maslen C., Steiner R.D., Porter F.D.;
RT   "Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz
RT   syndrome patients: polymerase chain reaction-based assays to simplify
RT   genotyping.";
RL   Am. J. Med. Genet. 94:214-227(2000).
RN   [20]
RP   VARIANTS SLOS MET-93; PRO-109; LEU-119; MET-154; LEU-182; TYR-183;
RP   GLU-198; HIS-242; ARG-244; CYS-248 AND LEU-255.
RX   PubMed=11427181; DOI=10.1046/j.1469-1809.2001.6530229.x;
RA   Jira P.E., Wanders R.J.A., Smeitink J.A.M., De Jong J., Wevers R.A.,
RA   Oostheim W., Tuerlings J.H.A.M., Hennekam R.C.M., Sengers R.C.A.,
RA   Waterham H.R.;
RT   "Novel mutations in the 7-dehydrocholesterol reductase gene of 13
RT   patients with Smith-Lemli-Opitz syndrome.";
RL   Ann. Hum. Genet. 65:229-236(2001).
RN   [21]
RP   VARIANTS SLOS MET-93; LEU-326; TRP-352 AND CYS-404.
RX   PubMed=11175299; DOI=10.1038/sj.ejhg.5200579;
RA   Witsch-Baumgartner M., Ciara E., Loffler J., Menzel H.J., Seedorf U.,
RA   Burn J., Gillessen-Kaesbach G., Hoffmann G.F., Fitzky B.U., Mundy H.,
RA   Clayton P., Kelley R.I., Krajewska-Walasek M., Utermann G.;
RT   "Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-
RT   Opitz syndrome in Europe: evidence for different origins of common
RT   mutations.";
RL   Eur. J. Hum. Genet. 9:45-50(2001).
RN   [22]
RP   VARIANT SLOS LYS-448.
RX   PubMed=12949967; DOI=10.1002/ajmg.a.20207;
RA   Langius F.A., Waterham H.R., Romeijn G.J., Oostheim W., de Barse M.M.,
RA   Dorland L., Duran M., Beemer F.A., Wanders R.J., Poll-The B.T.;
RT   "Identification of three patients with a very mild form of Smith-
RT   Lemli-Opitz syndrome.";
RL   Am. J. Med. Genet. A 122:24-29(2003).
RN   [23]
RP   VARIANTS SLOS PRO-68; CYS-113; VAL-138; LEU-145; SER-235; CYS-242;
RP   THR-297; ARG-344; CYS-404; TYR-405; HIS-408 AND PRO-426.
RX   PubMed=15954111; DOI=10.1002/humu.9346;
RA   Waye J.S., Krakowiak P.A., Wassif C.A., Sterner A.L., Eng B.,
RA   Nakamura L.M., Nowaczyk M.J.M., Porter F.D.;
RT   "Identification of nine novel DHCR7 missense mutations in patients
RT   with Smith-Lemli-Opitz syndrome (SLOS).";
RL   Hum. Mutat. 26:59-59(2005).
RN   [24]
RP   VARIANT ARG-118.
RX   PubMed=25787250; DOI=10.1073/pnas.1503696112;
RA   Cromer M.K., Choi M., Nelson-Williams C., Fonseca A.L., Kunstman J.W.,
RA   Korah R.M., Overton J.D., Mane S., Kenney B., Malchoff C.D.,
RA   Stalberg P., Akerstroem G., Westin G., Hellman P., Carling T.,
RA   Bjoerklund P., Lifton R.P.;
RT   "Neomorphic effects of recurrent somatic mutations in Yin Yang 1 in
RT   insulin-producing adenomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:4062-4067(2015).
CC   -!- FUNCTION: Production of cholesterol by reduction of C7-C8 double
CC       bond of 7-dehydrocholesterol (7-DHC).
CC   -!- CATALYTIC ACTIVITY: Cholesterol + NADP(+) = cholesta-5,7-dien-3-
CC       beta-ol + NADPH.
CC   -!- PATHWAY: Steroid biosynthesis; cholesterol biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:9878250}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:9878250}.
CC   -!- TISSUE SPECIFICITY: Most abundant in adrenal gland, liver, testis,
CC       and brain. {ECO:0000269|PubMed:9878250}.
CC   -!- DISEASE: Smith-Lemli-Opitz syndrome (SLOS) [MIM:270400]: An
CC       autosomal recessive frequent inborn disorder of sterol metabolism
CC       with characteristic congenital malformations and mental
CC       retardation. Children with SLOS have elevated serum 7-
CC       dehydrocholesterol (7-DHC) levels and low serum cholesterol
CC       levels. SLOS occurs in relatively high frequency: approximately 1
CC       in 20,000 to 30,000 births in populations of northern and central
CC       European background. Historically, a clinical distinction often
CC       was made between classic ('type I') SLOS and the more severely
CC       affected ('type II') patients. There is, in reality, a clinical
CC       and biochemical continuum from mild to severe SLOS.
CC       {ECO:0000269|PubMed:10677299, ECO:0000269|PubMed:10995508,
CC       ECO:0000269|PubMed:11175299, ECO:0000269|PubMed:11427181,
CC       ECO:0000269|PubMed:12949967, ECO:0000269|PubMed:15954111,
CC       ECO:0000269|PubMed:9653161, ECO:0000269|PubMed:9683613}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the ERG4/ERG24 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF096305; AAD09766.1; -; mRNA.
DR   EMBL; AF034544; AAC05086.1; -; mRNA.
DR   EMBL; AF110060; AAD24762.1; -; Genomic_DNA.
DR   EMBL; AF067127; AAD02816.1; -; mRNA.
DR   EMBL; AK312775; BAG35639.1; -; mRNA.
DR   EMBL; BC000054; AAH00054.1; -; mRNA.
DR   EMBL; AF062481; AAC18345.1; -; mRNA.
DR   CCDS; CCDS8200.1; -.
DR   RefSeq; NP_001157289.1; NM_001163817.1.
DR   RefSeq; NP_001351.2; NM_001360.2.
DR   UniGene; Hs.503134; -.
DR   ProteinModelPortal; Q9UBM7; -.
DR   BioGrid; 108063; 18.
DR   IntAct; Q9UBM7; 19.
DR   MINT; MINT-4651013; -.
DR   STRING; 9606.ENSP00000347717; -.
DR   BindingDB; Q9UBM7; -.
DR   ChEMBL; CHEMBL2169735; -.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000001078; -.
DR   iPTMnet; Q9UBM7; -.
DR   PhosphoSitePlus; Q9UBM7; -.
DR   SwissPalm; Q9UBM7; -.
DR   BioMuta; DHCR7; -.
DR   DMDM; 20138066; -.
DR   EPD; Q9UBM7; -.
DR   MaxQB; Q9UBM7; -.
DR   PaxDb; Q9UBM7; -.
DR   PeptideAtlas; Q9UBM7; -.
DR   PRIDE; Q9UBM7; -.
DR   DNASU; 1717; -.
DR   Ensembl; ENST00000355527; ENSP00000347717; ENSG00000172893.
DR   Ensembl; ENST00000407721; ENSP00000384739; ENSG00000172893.
DR   GeneID; 1717; -.
DR   KEGG; hsa:1717; -.
DR   UCSC; uc001oqk.4; human.
DR   CTD; 1717; -.
DR   DisGeNET; 1717; -.
DR   GeneCards; DHCR7; -.
DR   GeneReviews; DHCR7; -.
DR   HGNC; HGNC:2860; DHCR7.
DR   HPA; HPA044280; -.
DR   MalaCards; DHCR7; -.
DR   MIM; 270400; phenotype.
DR   MIM; 602858; gene.
DR   neXtProt; NX_Q9UBM7; -.
DR   OpenTargets; ENSG00000172893; -.
DR   Orphanet; 818; Smith-Lemli-Opitz syndrome.
DR   PharmGKB; PA27321; -.
DR   eggNOG; KOG1435; Eukaryota.
DR   eggNOG; ENOG410XP67; LUCA.
DR   GeneTree; ENSGT00390000000417; -.
DR   HOGENOM; HOG000193296; -.
DR   HOVERGEN; HBG007825; -.
DR   InParanoid; Q9UBM7; -.
DR   KO; K00213; -.
DR   OMA; NGKCLVW; -.
DR   OrthoDB; EOG091G0F22; -.
DR   PhylomeDB; Q9UBM7; -.
DR   TreeFam; TF101180; -.
DR   BioCyc; MetaCyc:HS10588-MONOMER; -.
DR   BRENDA; 1.3.1.21; 2681.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-6807047; Cholesterol biosynthesis via desmosterol.
DR   Reactome; R-HSA-6807062; Cholesterol biosynthesis via lathosterol.
DR   SABIO-RK; Q9UBM7; -.
DR   UniPathway; UPA00063; -.
DR   ChiTaRS; DHCR7; human.
DR   GeneWiki; 7-Dehydrocholesterol_reductase; -.
DR   GenomeRNAi; 1717; -.
DR   PRO; PR:Q9UBM7; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000172893; -.
DR   CleanEx; HS_DHCR7; -.
DR   ExpressionAtlas; Q9UBM7; baseline and differential.
DR   Genevisible; Q9UBM7; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005640; C:nuclear outer membrane; IDA:UniProtKB.
DR   GO; GO:0047598; F:7-dehydrocholesterol reductase activity; IDA:UniProtKB.
DR   GO; GO:0050661; F:NADP binding; ISS:UniProtKB.
DR   GO; GO:0009918; F:sterol delta7 reductase activity; IBA:GO_Central.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0016132; P:brassinosteroid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0030154; P:cell differentiation; IEA:Ensembl.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0033489; P:cholesterol biosynthetic process via desmosterol; TAS:Reactome.
DR   GO; GO:0033490; P:cholesterol biosynthetic process via lathosterol; TAS:Reactome.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045540; P:regulation of cholesterol biosynthetic process; IEA:Ensembl.
DR   InterPro; IPR001171; Ergosterol_biosynth_ERG4_ERG24.
DR   InterPro; IPR018083; Sterol_reductase_CS.
DR   Pfam; PF01222; ERG4_ERG24; 1.
DR   PROSITE; PS01017; STEROL_REDUCT_1; 1.
DR   PROSITE; PS01018; STEROL_REDUCT_2; 1.
PE   1: Evidence at protein level;
KW   Cholesterol biosynthesis; Cholesterol metabolism; Complete proteome;
KW   Disease mutation; Endoplasmic reticulum; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; NADP; Oxidoreductase; Phosphoprotein;
KW   Polymorphism; Reference proteome; Steroid biosynthesis;
KW   Steroid metabolism; Sterol biosynthesis; Sterol metabolism;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    475       7-dehydrocholesterol reductase.
FT                                /FTId=PRO_0000207502.
FT   TRANSMEM     40     60       Helical. {ECO:0000255}.
FT   TRANSMEM    154    174       Helical. {ECO:0000255}.
FT   TRANSMEM    177    197       Helical. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical. {ECO:0000255}.
FT   TRANSMEM    306    326       Helical. {ECO:0000255}.
FT   TRANSMEM    331    351       Helical. {ECO:0000255}.
FT   TRANSMEM    420    440       Helical. {ECO:0000255}.
FT   NP_BIND     407    408       NADP. {ECO:0000250|UniProtKB:G4SW86}.
FT   NP_BIND     451    455       NADP. {ECO:0000250|UniProtKB:G4SW86}.
FT   BINDING     358    358       NADP. {ECO:0000250|UniProtKB:G4SW86}.
FT   BINDING     362    362       NADP. {ECO:0000250|UniProtKB:G4SW86}.
FT   BINDING     395    395       NADP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000250|UniProtKB:G4SW86}.
FT   BINDING     400    400       NADP. {ECO:0000250|UniProtKB:G4SW86}.
FT   BINDING     447    447       NADP. {ECO:0000250|UniProtKB:G4SW86}.
FT   BINDING     462    462       NADP. {ECO:0000250|UniProtKB:G4SW86}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VARIANT       5      5       S -> L (in dbSNP:rs1127869).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:9465114}.
FT                                /FTId=VAR_067456.
FT   VARIANT      51     51       P -> S (in SLOS; dbSNP:rs104886035).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012717.
FT   VARIANT      68     68       L -> P (in SLOS; dbSNP:rs104886038).
FT                                {ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023148.
FT   VARIANT      93     93       T -> M (in SLOS; dbSNP:rs80338853).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:11175299,
FT                                ECO:0000269|PubMed:11427181,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012718.
FT   VARIANT      99     99       L -> P (in SLOS; dbSNP:rs104886041).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012719.
FT   VARIANT     107    107       Q -> H (in SLOS; dbSNP:rs104886040).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023149.
FT   VARIANT     109    109       L -> P (in SLOS; dbSNP:rs121912195).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:11427181}.
FT                                /FTId=VAR_023150.
FT   VARIANT     113    113       S -> C (in SLOS).
FT                                {ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023151.
FT   VARIANT     118    118       C -> R. {ECO:0000269|PubMed:25787250}.
FT                                /FTId=VAR_074180.
FT   VARIANT     119    119       H -> L (in SLOS; dbSNP:rs28938174).
FT                                {ECO:0000269|PubMed:11427181,
FT                                ECO:0000269|PubMed:9683613}.
FT                                /FTId=VAR_012720.
FT   VARIANT     138    138       G -> V (in SLOS).
FT                                {ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023152.
FT   VARIANT     145    145       I -> L (in SLOS).
FT                                {ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023153.
FT   VARIANT     147    147       G -> D (in SLOS; dbSNP:rs777425801).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023154.
FT   VARIANT     154    154       T -> M (in SLOS; dbSNP:rs143312232).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:11427181}.
FT                                /FTId=VAR_023155.
FT   VARIANT     157    157       L -> P (in SLOS; dbSNP:rs753960624).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012721.
FT   VARIANT     169    169       S -> L (in SLOS; dbSNP:rs80338855).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023156.
FT   VARIANT     182    182       W -> C (in SLOS).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023157.
FT   VARIANT     182    182       W -> L (in SLOS).
FT                                {ECO:0000269|PubMed:11427181}.
FT                                /FTId=VAR_023158.
FT   VARIANT     183    183       C -> Y (in SLOS).
FT                                {ECO:0000269|PubMed:11427181}.
FT                                /FTId=VAR_023159.
FT   VARIANT     198    198       K -> E (in SLOS).
FT                                {ECO:0000269|PubMed:11427181}.
FT                                /FTId=VAR_023160.
FT   VARIANT     235    235       F -> S (in SLOS).
FT                                {ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023161.
FT   VARIANT     242    242       R -> C (in SLOS; dbSNP:rs80338856).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023162.
FT   VARIANT     242    242       R -> H (in SLOS; dbSNP:rs80338857).
FT                                {ECO:0000269|PubMed:11427181}.
FT                                /FTId=VAR_023163.
FT   VARIANT     244    244       G -> R (in SLOS; dbSNP:rs121909764).
FT                                {ECO:0000269|PubMed:11427181,
FT                                ECO:0000269|PubMed:9683613}.
FT                                /FTId=VAR_012722.
FT   VARIANT     247    247       A -> V (in SLOS).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012723.
FT   VARIANT     248    248       W -> C (in SLOS; dbSNP:rs28939698).
FT                                {ECO:0000269|PubMed:11427181,
FT                                ECO:0000269|PubMed:9683613}.
FT                                /FTId=VAR_012724.
FT   VARIANT     255    255       F -> L (in SLOS).
FT                                {ECO:0000269|PubMed:11427181}.
FT                                /FTId=VAR_023164.
FT   VARIANT     281    281       V -> M (in SLOS; dbSNP:rs398123607).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023165.
FT   VARIANT     289    289       T -> I (in SLOS; dbSNP:rs121909765).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:10995508}.
FT                                /FTId=VAR_012725.
FT   VARIANT     297    297       I -> T (in SLOS).
FT                                {ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023166.
FT   VARIANT     311    311       C -> G (in SLOS).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023167.
FT   VARIANT     311    311       C -> Y (in SLOS).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023168.
FT   VARIANT     324    324       Y -> H (in SLOS).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023169.
FT   VARIANT     326    326       V -> L (in SLOS; dbSNP:rs80338859).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:11175299,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012726.
FT   VARIANT     344    344       G -> R (in SLOS).
FT                                {ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023170.
FT   VARIANT     352    352       R -> Q (in SLOS; dbSNP:rs121909768).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023171.
FT   VARIANT     352    352       R -> W (in SLOS; dbSNP:rs80338860).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:11175299,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012727.
FT   VARIANT     353    353       V -> A (in SLOS).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023172.
FT   VARIANT     362    362       R -> C (in SLOS; dbSNP:rs371302153).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023173.
FT   VARIANT     380    380       C -> R (in SLOS; dbSNP:rs373306653).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023174.
FT   VARIANT     380    380       C -> S (in SLOS).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012728.
FT   VARIANT     380    380       C -> Y (in SLOS; dbSNP:rs779709646).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023175.
FT   VARIANT     397    397       S -> L (in SLOS; dbSNP:rs773134475).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023176.
FT   VARIANT     404    404       R -> C (in SLOS; dbSNP:rs61757582).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:11175299,
FT                                ECO:0000269|PubMed:15954111,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012729.
FT   VARIANT     404    404       R -> S (in SLOS).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023177.
FT   VARIANT     405    405       H -> Y (in SLOS).
FT                                {ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023178.
FT   VARIANT     408    408       Y -> H (in SLOS).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023179.
FT   VARIANT     410    410       G -> R (in SLOS).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023180.
FT   VARIANT     410    410       G -> S (in SLOS; dbSNP:rs80338862).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:9653161}.
FT                                /FTId=VAR_012730.
FT   VARIANT     425    425       G -> S (in dbSNP:rs760242).
FT                                /FTId=VAR_052154.
FT   VARIANT     426    426       H -> P (in SLOS).
FT                                {ECO:0000269|PubMed:15954111}.
FT                                /FTId=VAR_023181.
FT   VARIANT     443    443       R -> C (in SLOS; dbSNP:rs535561852).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023182.
FT   VARIANT     446    446       R -> Q (in SLOS; dbSNP:rs751604696).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023183.
FT   VARIANT     448    448       E -> K (in SLOS; mild; dbSNP:rs80338864).
FT                                {ECO:0000269|PubMed:10677299,
FT                                ECO:0000269|PubMed:12949967}.
FT                                /FTId=VAR_016975.
FT   VARIANT     448    448       E -> Q (in SLOS).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023184.
FT   VARIANT     450    450       R -> L (in SLOS; dbSNP:rs542266962).
FT                                {ECO:0000269|PubMed:10677299}.
FT                                /FTId=VAR_023185.
FT   CONFLICT     14     14       S -> A (in Ref. 6; AAC18345).
FT                                {ECO:0000305}.
SQ   SEQUENCE   475 AA;  54489 MW;  7D726443834C4EEB CRC64;
     MAAKSQPNIP KAKSLDGVTN DRTASQGQWG RAWEVDWFSL ASVIFLLLFA PFIVYYFIMA
     CDQYSCALTG PVVDIVTGHA RLSDIWAKTP PITRKAAQLY TLWVTFQVLL YTSLPDFCHK
     FLPGYVGGIQ EGAVTPAGVV NKYQINGLQA WLLTHLLWFA NAHLLSWFSP TIIFDNWIPL
     LWCANILGYA VSTFAMVKGY FFPTSARDCK FTGNFFYNYM MGIEFNPRIG KWFDFKLFFN
     GRPGIVAWTL INLSFAAKQR ELHSHVTNAM VLVNVLQAIY VIDFFWNETW YLKTIDICHD
     HFGWYLGWGD CVWLPYLYTL QGLYLVYHPV QLSTPHAVGV LLLGLVGYYI FRVANHQKDL
     FRRTDGRCLI WGRKPKVIEC SYTSADGQRH HSKLLVSGFW GVARHFNYVG DLMGSLAYCL
     ACGGGHLLPY FYIIYMAILL THRCLRDEHR CASKYGRDWE RYTAAVPYRL LPGIF
//
